Moreover, Ang-2 inhibition also suppresses the in vivo metastasis of HCC, suggesting that this Ang-2-dependent VETC pattern is involved in HCC metastasis [48]. This evidence concerns the gene ANGPT2 and hepatocellular carcinoma.